# Progress Note 03 — Sick Visit

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Vincent van Gogh (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-NI010-SYN
- Date: 2026-02-16
- Fictional facility: St. Posthumous Health Center
- Fictional author: Elise Verhoeven, MD
- Calendar frame: modern shifted

- Visit type: Sick Visit
- Services: Problem-oriented office visit, established patient

## Chief complaint

Restlessness and inability to sit still for five days. **S**

## History of present illness

Mr. van Gogh called the coordinated specialty care team and was seen the same day. Two weeks ago his aripiprazole was increased from 10 to 15 mg because he still heard his name called as he fell asleep. Since then the night-time voices have stopped, but for five days he has felt an inner restlessness he cannot switch off. He cannot sit at his easel for more than a few minutes, paces his studio, shifts his legs when sitting, and lies awake because his legs will not keep still. The feeling is worst in the late afternoon, a few hours after his morning dose. He was frightened that the illness was coming back, and the restlessness makes him irritable and miserable. He has had no confusion, no voices by day, and no stiffness or tremor. He has taken naltrexone daily, has had one or two drinks on three evenings this week, and has not drunk more to calm the feeling. He has not had thoughts of suicide or self-harm; the passive thoughts of not waking up have not returned. **S**

| Element | Detail |
|---|---|
| Onset | Five days ago, nine days after the aripiprazole increase to 15 mg |
| Location | Inner restlessness, mainly in the legs |
| Duration | Five days, constant |
| Character | An urge to move that he cannot resist; pacing; shifting his legs while sitting |
| Severity | Moderate; cannot paint or sleep through it |
| Timing | Worst in the late afternoon |
| Context | Aripiprazole increased from 10 to 15 mg two weeks ago |
| Modifying factors | Walking eases it briefly; coffee makes it worse |
| Associated signs and symptoms | Poor sleep and irritability; no voices by day, confusion, stiffness, tremor, fever, or thoughts of suicide or self-harm |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | No fever or sweats |
| Neurological | Positive | Restless legs and an urge to move; no stiffness, tremor, abnormal movements of the face or tongue, or weakness |
| Cardiovascular | Negative | No palpitations, fainting, or chest pain |
| Respiratory | Negative | No wheeze or asthma |
| Psychiatric | Positive | Anxious and irritable with the restlessness; poor sleep; no voices by day; no thoughts of suicide or self-harm |

5 systems reviewed. **S**

## Current medications

- Naltrexone 50 mg oral tablet, one tablet by mouth once daily **S**
- Thiamine 100 mg oral tablet, one tablet by mouth daily (started in hospital) **S**
- Aripiprazole 10 mg oral tablet, one tablet by mouth once daily **S**
- Propranolol 10 mg oral tablet, one tablet by mouth twice daily for akathisia **S**

## Allergies

- No known allergy **S**

## Objective

BP 130/82 mmHg; pulse 96 bpm; respirations 16/min; temperature 36.7 °C; oxygen saturation 98% on room air; weight 64.4 kg; BMI 22.3 kg/m². All vital signs are synthetic.

No condition-specific results recorded.

## Physical examination

| System | Finding |
|---|---|
| General | Restless; stands and walks twice during the visit; blood pressure 130/82, pulse 96 |
| Neurological | Shifts his weight and crosses and uncrosses his legs while seated; Barnes global akathisia rating 3 (moderate); no rigidity, cogwheeling, tremor, or abnormal facial or tongue movements; gait normal |
| Cardiovascular | Regular rhythm; no murmur |
| Respiratory | Clear; no wheeze |
| Psychiatric | Distressed by the restlessness but organized and engaged; no hallucinations or delusions elicited |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Akathisia from aripiprazole** (G25.71). Moderate akathisia after the dose increase: subjective restlessness with observed movement, without parkinsonism or dyskinesia. It is not a return of the psychosis. Akathisia is distressing and is linked with impulsive behavior and suicidal thoughts, so it is treated promptly. Asthma and a slow pulse, which would prevent propranolol, are absent. A benzodiazepine is avoided because of his alcohol use. **S**
   - Return aripiprazole to 10 mg daily from tomorrow.
   - Propranolol 10 mg twice daily for a few weeks.
   - Cut coffee to one cup in the morning.
   - Phone check from the care coordinator in three days.
2. **First episode of psychosis, provisional diagnosis** (F29). No voices since the increase; the lower dose may let them return, so he and the team will watch for them. Safety reviewed: no thoughts of suicide or self-harm; the safety plan and the 988 Suicide & Crisis Lifeline are in his phone, and he knows akathisia can make him feel desperate and to call if it does. **S**
   - If night-time voices return on 10 mg, the team will review the dose at the six-week visit rather than raise it now.
   - Six-week visit as planned.
3. **Alcohol use disorder on naltrexone** (F10.20). One or two drinks on three evenings this week; he has not used alcohol to calm the restlessness. **S**
   - Continue naltrexone and thiamine.
   - No alcohol to treat the restlessness or to get to sleep.

## Medication changes

- Stopped: Aripiprazole 15 mg oral tablet, one tablet by mouth once daily **S**
- Started: Aripiprazole 10 mg oral tablet, one tablet by mouth once daily **S**
- Started: Propranolol 10 mg oral tablet, one tablet by mouth twice daily for akathisia **S**

## Guideline basis

- The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia, Third Edition (2020), American Psychiatric Association (American Journal of Psychiatry)
- VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024), United States Department of Veterans Affairs and Department of Defense

## Follow-up

- Care coordinator phone check in three days. Six-week visit in two weeks, or sooner if the restlessness does not ease within a week or if voices or dark thoughts return. **S**
- Next scheduled visit 2026-03-02: six-week review: symptoms, side effects, alcohol, sleep, and test results. **S**
